EO 14398; somafocus 3D MEA system for electrophysiology recording inside in-vitro 3D ipsc culture derived organoids
Active Purchase Order Awarded
- Contract number
- 75F40126P00285
- Awardee
-
Diagnostic Biochips, Inc. UEI PF2EA6V5G9E3
- Awarding agency
-
Food and Drug Administration
Department of Health and Human Services
- Obligated
- $179,100
Award facts
- Opportunity
-
- SomaFocus, or Equal 3D multi-electrode array (MEA) System plus four (4) option years of Preventive Maintenance and unlimited repairs Solicitation · 75F40126Q135970 · Posted Aug 28, 2026
- Contract value 65% obligated
-
- $179,100.00 Current, with exercised options
- $275,100.00 Potential, with all options
- Completion date 3% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 334516 Analytical Laboratory Instrument Manufacturing
- PSC
- 6640 Laboratory Equipment And Supplies
- Set-aside
- Total Small Business
- Competition
- Competed under SAP · 2 offers Simplified Acquisition
- Pricing
- Firm Fixed Price
- Place of performance
- Glen Burnie, MD, USA
Award details come from SAM.gov/FPDS.
About this award
The Food and Drug Administration awarded a purchase order to Diagnostic Biochips, Inc. for a SomaFocus 3D multi-electrode array (MEA) system on September 9, 2026, with a ceiling value of $275,100 under a total small business set-aside. Performance occurs in Glen Burnie, Maryland. The order covers a newly manufactured 3D MEA system capable of recording electrophysiological signals from human iPSC-derived brain organoids with penetration depths to 200 micrometers and minimum sampling rates of 10 kHz per electrode, together with factory-certified installation, one day of operator training for two attendees, comprehensive one-year warranty with platinum service, application software with cloud backup, and a consumables pack containing 60 custom microwell plates and 60 organoid probes. Four optional one-year post-warranty maintenance and repair agreements are available. Delivery is expected by November 30, 2026, with warranty through November 29, 2027. The contract is firm fixed price. Ultimate completion is December 9, 2031.
Quick answers
Who was awarded contract 75F40126P00285?
75F40126P00285 was awarded to Diagnostic Biochips, Inc. by Food and Drug Administration (Department of Health and Human Services) on September 9, 2026.
How much is contract 75F40126P00285 worth?
The government has obligated $179,100 on 75F40126P00285. Its potential value, with all options, is $275,100.
Was contract 75F40126P00285 competed?
The extent of competition for 75F40126P00285 was competed under sap. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award